- Home
- ACAD vs BSM Comparison
ACAD vs BSM Comparison
Compare ACAD & BSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- BSM
- Stock Information
- Founded
- ACAD 1993
- BSM 1876
- Country
- ACAD United States
- BSM United States
- Employees
- ACAD N/A
- BSM N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- BSM Oil & Gas Production
- Sector
- ACAD Health Care
- BSM Energy
- Exchange
- ACAD Nasdaq
- BSM Nasdaq
- Market Cap
- ACAD 2.8B
- BSM 2.9B
- IPO Year
- ACAD 2004
- BSM 2015
- Fundamental
- Price
- ACAD $17.57
- BSM $15.58
- Analyst Decision
- ACAD Buy
- BSM Buy
- Analyst Count
- ACAD 19
- BSM 3
- Target Price
- ACAD $26.17
- BSM $17.00
- AVG Volume (30 Days)
- ACAD 4.3M
- BSM 529.9K
- Earning Date
- ACAD 02-25-2025
- BSM 02-18-2025
- Dividend Yield
- ACAD N/A
- BSM 9.62%
- EPS Growth
- ACAD N/A
- BSM N/A
- EPS
- ACAD 0.78
- BSM 1.64
- Revenue
- ACAD $929,236,000.00
- BSM $457,207,000.00
- Revenue This Year
- ACAD $36.78
- BSM N/A
- Revenue Next Year
- ACAD $8.19
- BSM $0.32
- P/E Ratio
- ACAD $22.63
- BSM $9.53
- Revenue Growth
- ACAD 47.06
- BSM N/A
- 52 Week Low
- ACAD $14.15
- BSM $13.78
- 52 Week High
- ACAD $29.29
- BSM $16.92
- Technical
- Relative Strength Index (RSI)
- ACAD 52.06
- BSM 70.38
- Support Level
- ACAD $16.61
- BSM $14.31
- Resistance Level
- ACAD $18.23
- BSM $15.39
- Average True Range (ATR)
- ACAD 0.74
- BSM 0.26
- MACD
- ACAD -0.05
- BSM 0.15
- Stochastic Oscillator
- ACAD 36.59
- BSM 98.77
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
About BSM Black Stone Minerals L.P. Common units representing limited partner interests
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.